Metals and Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 10, Issue 2-3, 2006, Pages 145-163

  Adlard, Paul A ^a   Bush, Ashley I ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CELL PROTEIN; CHELATING AGENT; CHLOROTRIANISENE; CLIOQUINOL; COPPER; CYTOSKELETON PROTEIN; DP 109; HEAVY METAL; HISTIDINE; INSULINASE; IRON; LEAD; MANGANESE; MEMBRANE METALLOENDOPEPTIDASE; METAL ION; PLACEBO; REACTIVE OXYGEN METABOLITE; TRANSITION ELEMENT; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; ZINC;

AGING; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CYTOSKELETON; DRUG EFFECT; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HUMAN; INTELLIGENCE QUOTIENT; METAL BINDING; MINI MENTAL STATE EXAMINATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; REVIEW;

EID: 33751074919     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-102-303     Document Type: Review

References (235)

1. A.Y. Abramov, L. Canevari and M.R. Duchen, Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity, J Neurosci 23 (2003), 5088-5095.
2. P.A. Adlard, A.K. West and J.C. Vickers, Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease, Neurobiol Dis 5 (1998), 349-356.
3. N. Ahluwalia, M.A. Gordon, G. Handte, M. Mahlon, N.Q. Li, J.L. Beard, D. Weinstock and A.C. Ross, Iron status and stores decline with age in Lewis rats, J Nutr 130 (2000), 2378-2383.
4. W.L. An, C. Bjorkdahl, R. Liu, R.F. Cowburn, B. Winblad and J.J. Pei, Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SHSY5Y neuroblastoma cells, J Neurochem 92 (2005), 1104-1115.
5. A. Andreadis, Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases, Biochim Biophys Acta 1739 (2005), 91-103.
6. B. Angeletti, K.J. Waldron, K.B. Freeman, H. Bawagan, I. Hussain, C.C. Miller, K.F. Lau, M.E. Tennant, C. Dennison, N.J. Robinson and C. Dingwall, BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper, J Biol Chem 280 (2005), 17930-17937.
7. S. Arlt, U. Beisiegel and A. Kontush, Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease, Curr Opin Lipidol 13 (2002), 289-294.
8. A.D. Armendariz, M. Gonzalez, A.V. Loguinov and C.D. Vulpe, Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App, Physiol Genomics 20 (2004), 45-54.
9. C.S. Atwood, X. Huang, A. Khatri, R.C. Scarpa, Y.S. Kim, R.D. Moir, R.E. Tanzi, A.E. Roher and A.I. Bush, Copper catalyzed oxidation of Alzheimer Abeta, Cell Mol Biol (Noisy-le-grand) 46 (2000), 777-783.
10. C.S. Atwood, R.D. Moir, X. Huang, R.C. Scarpa, N.M. Bacarra, D.M. Romano, M.A. Hartshorn, R.E. Tanzi and A.I. Bush, Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis, J Biol Chem 273 (1998), 12817-12826.
11. C.S. Atwood, G. Perry, H. Zeng, Y. Kato, W.D. Jones, K.Q. Ling, X. Huang, R.D. Moir, D. Wang, L.M. Sayre, M.A. Smith, S.G. Chen and A.I. Bush, Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta, Biochemistry 43 (2004), 560-568.
12. C.S. Atwood, R.C. Scarpa, X. Huang, R.D. Moir, W.D. Jones, D.P. Fairlie, R.E. Tanzi and A.I. Bush, Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42, J Neurochem 75 (2000), 1219-1233.
13. G. Barja, Free radicals and aging, Trends Neurosci 27 (2004), 595-600.
14. K.J. Barnham, G.D. Ciccotosto, A.K. Tickler, F.E. Ali, D.G. Smith, N.A. Williamson, Y.H. Lam, D. Carrington, D. Tew, G. Kocak, I. Volitakis, F. Separovic, C.J. Barrow, J.D.Wade, C.L. Masters, R.A. Cherny, C.C. Curtain, A.I. Bush and R. Cappai, Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation, J Biol Chem 278 (2003), 42959-42965.
15. K.J. Barnham, F. Haeffner, G.D. Ciccotosto, C.C. Curtain, D. Tew, C. Mavros, K. Beyreuther, D. Carrington, C.L. Masters, R.A. Cherny, R. Cappai and A.I. Bush, Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid, Faseb J 18 (2004), 1427-1429.
16. K.J. Barnham, W.J. McKinstry, G. Multhaup, D. Galatis, C.J. Morton, C.C. Curtain, N.A. Williamson, A.R. White, M.G. Hinds, R.S. Norton, K. Beyreuther, C.L. Masters, M.W. Parker and R. Cappai, Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis, J Biol Chem 278 (2003), 17401-17407.
17. M.R. Basha, M. Murali, H.K. Siddiqi, K. Ghosal, O.K. Siddiqi, H.A. Lashuel, Y.W. Ge, D.K. Lahiri and N.H. Zawia, Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation, Faseb J (2005).
18. M.R. Basha, W. Wei, S.A. Bakheet, N. Benitez, H.K. Siddiqi, Y.W. Ge, D.K. Lahiri and N.H. Zawia, The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain, J Neurosci 25 (2005), 823-829.
19. H. Basun, L.G. Forssell, L. Wetterberg and B. Winblad, Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease, J Neural Transm Park Dis Dement Sect 3 (1991), 231-258.
20. T.A. Bayer, S. Schafer, A. Simons, A. Kemmling, T. Kamer, R. Tepest, A. Eckert, K. Schussel, O. Eikenberg, C. Sturchler-Pierrat, D. Abramowski, M. Staufenbiel and G. Multhaup, Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice, Proc Natl Acad Sci USA 100 (2003), 14187-14192.
21. C. Behl, J.B. Davis, R. Lesley and D. Schubert, Hydrogen peroxide mediates amyloid beta protein toxicity, Cell 77 (1994), 817-827.
22. S.A. Bellingham, G.D. Ciccotosto, B.E. Needham, L.R. Fodero, A.R. White, C.L. Masters, R. Cappai and J. Camakaris, Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts, J Neurochem 91 (2004), 423-428.
23. S.A. Bellingham, D.K. Lahiri, B. Maloney, S. La Fontaine, G. Multhaup and J. Camakaris, Copper depletion downregulates expression of the Alzheimer's disease amyloid-beta precursor protein gene, J Biol Chem 279 (2004), 20378-20386.
24. S. Bhatnagar and S. Taneja, Zinc and cognitive development, Br J Nutr 85(2) (2001), S139-145.
25. G.M. Bishop, S.R. Robinson, Q. Liu, G. Perry, C.S. Atwood and M.A. Smith, Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24 (2002), 184-187.
26. C. Bjorkdahl, M.J. Sjogren, B. Winblad and J.J. Pei, Zinc induces neurofilament phosphorylation independent of p70 S6 kinase in N2a cells, Neuroreport 16 (2005), 591-595.
27. M.L. Bleecker, D.P. Ford, K.N. Lindgren, V.M. Hoese, K.S. Walsh and C.G. Vaughan, Differential effects of lead exposure on components of verbal memory, Occup Environ Med 62 (2005), 181-187.
28. T. Borchardt, J. Camakaris, R. Cappai, C.L. Masters, K. Beyreuther and G. Multhaup, Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion, Biochem J 344(2) (1999), 461-467.
29. C. Bouras, P. Giannakopoulos, P.F. Good, A. Hsu, P.R. Hof and D.P. Perl, A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease, Eur Neurol 38 (1997), 53-58.
30. A.M. Brown, D.M. Tummolo, K.J. Rhodes, J.R. Hofmann, J.S. Jacobsen and J. Sonnenberg-Reines, Selective aggregation of endogenous beta-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc, J Neurochem 69 (1997), 1204-1212.
31. C.A. Buckley, F.N. Rouhani, M. Kaler, B. Adamik, F.I. Hawari and S.J. Levine, Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch, Am J Physiol Lung Cell Mol Physiol 288 (2005), L1132-1138.
32. V.W. Bunker, L.J. Hinks, M.F. Stansfield, M.S. Lawson and B.E. Clayton, Metabolic balance studies for zinc and copper in housebound elderly people and the relationship between zinc balance and leukocyte zinc concentrations, Am J Clin Nutr 46 (1987), 353-359.
33. A.I. Bush, G. Multhaup, R.D. Moir, T.G. Williamson, D.H. Small, B. Rumble, P. Pollwein, K. Beyreuther and C.L. Masters, A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease, J Biol Chem 268 (1993), 16109-16112.
34. A.I. Bush, W.H. Pettingell, Jr., M. de Paradis, R.E. Tanzi and W. Wasco, The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily, J Biol Chem 269 (1994), 26618-26621.
35. A.I. Bush, W.H. Pettingell, G. Multhaup, M.D. Paradis, J.P. Vonsattel, J.F. Gusella, K. Beyreuther, C.L. Masters and R.E. Tanzi, Rapid induction of Alzheimer A beta amyloid formation by zinc, Science 265 (1994), 1464-1467.
36. A.I. Bush, W.H. Pettingell, Jr., M.D. Paradis and R.E. Tanzi, Modulation of A beta adhesiveness and secretase site cleavage by zinc, J Biol Chem 269 (1994), 12152-12158.
37. D.A. Butterfield, A. Castegna, C.M. Lauderback and J. Drake, Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiol Aging 23 (2002), 655-664.
38. J.D. Buxbaum, K.N. Liu, Y. Luo, J.L. Slack, K.L. Stocking, J.J. Peschon, R.S. Johnson, B.J. Castner, D.P. Cerretti and R.A. Black, Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor, J Biol Chem 273 (1998), 27765-27767.
39. A. Caccamo, S. Oddo, M.C. Sugarman, Y. Akbari and F.M. LaFerla, Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders, Neurobiol Aging 26 (2005), 645-654.
40. H. Cai, Y. Wang, D. McCarthy, H. Wen, D.R. Borchelt, D.L. Price and P.C. Wong, BACE1 is the major beta-secretase for generation of Abeta peptides by neurons, Nat Neurosci 4 (2001), 233-234.
41. A. Campbell, M.A. Smith, L.M. Sayre, S.C. Bondy and G. Perry, Mechanisms by which metals promote events connected to neurodegenerative diseases, Brain Res Bull 55 (2001), 125-132.
42. S.M. Cardoso, M.T. Proenca, S. Santos, I. Santana and C.R. Oliveira, Cytochrome c oxidase is decreased in Alzheimer's disease platelets, Neurobiol Aging 25 (2004), 105-110.
43. G. Carrard, A.L. Bulteau, I. Petropoulos and B. Friguet, Impairment of proteasome structure and function in aging, Int J Biochem Cell Biol 34 (2002), 1461-1474.
44. J.A. Carson and A.J. Turner, Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem 81 (2002), 1-8.
45. W. Cerpa, L. Varela-Nallar, A.E. Reyes, A.N. Minniti and N.C. Inestrosa, Is there a role for copper in neurodegenerative diseases? Mol Aspects Med 26 (2005), 405-420.
46. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters and A.I. Bush, Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice, Neuron 30 (2001), 665-676.
47. R.A. Cherny, J.T.Legg, C.A. McLean, D.P. Fairlie, X. Huang, C.S. Atwood, K. Beyreuther, R.E. Tanzi, C.L. Masters and A.I. Bush, Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion, J Biol Chem 274 (1999), 23223-23228.
48. G.D. Ciccotosto, D. Tew, C.C. Curtain, D. Smith, D. Carrington, C.L. Masters, A.I. Bush, R.A. Cherny, R. Cappai and K.J. Barnham, Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution, J Biol Chem 279 (2004), 42528-42534.
49. E.D. Ciuculescu, Y. Mekmouche and P. Faller, Metal-binding properties of the peptide APP(170-188): a model of the Zn(II)-binding site of amyloid precursor protein (APP), Chemistry 11 (2005), 903-909.
50. J.R. Connor, P. Tucker, M. Johnson and B. Snyder, Cerulo-plasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease, Neurosci Lett 159 (1993), 88-90.
51. D.A. Cottrell, E.L. Blakely, M.A. Johnson, P.G. Ince and D.M. Turnbull, Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD, Neurology 57 (2001), 260-264.
52. J.B. Cross, J.S. Duca, J.J. Kaminski and V.S. Madison, The active site of a zinc-dependent metalloproteinase influences the computed pK(a) of ligands coordinated to the catalytic zinc ion, J Am Chem Soc 124 (2002), 11004-11007.
53. M.P. Cuajungco, L.E. Goldstein, A. Nunomura, M.A. Smith, J.T. Lim, C.S. Atwood, X. Huang, Y.W. Farrag, G. Perry and A.I. Bush, Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc, J Biol Chem 275 (2000), 19439-19442.
54. C.C. Curtain, F. Ali, I. Volitakis, R.A. Cherny, R.S. Norton, K. Beyreuther, C.J. Barrow, C.L. Masters, A.I. Bush and K.J. Barnham, Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J Biol Chem 276 (2001), 20466-20473.
55. C.C. Curtain, F.E. Ali, D.G. Smith, A.I. Bush, C.L. Masters and K.J. Barnham, Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid, J Biol Chem 278 (2003), 2977-2982.
56. K.N. Dahlgren, A.M. Manelli, W.B. Stine, Jr., L.K. Baker, G.A. Krafft and M.J. LaDu, Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability, J Biol Chem 277 (2002), 32046-32053.
57. G. Danscher, K.B. Jensen, C.J. Frederickson, K. Kemp, A. Andreasen, S. Juhl, M. Stoltenberg and R. Ravid, Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material, J Neurosci Methods 76 (1997), 53-59.
58. C.D. Davis, D.B. Milne and F.H. Nielsen, Changes in dietary zinc and copper affect zinc-status indicators of postmenopausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins, Am J Clin Nutr 71 (2000), 781-788.
59. P.P. De Deyn, M. Hiramatsu, F. Borggreve, J. Goeman, R. D'Hooge, J. Saerens and A. Mori, Superoxide dismutase activity in cerebrospinal fluid of patients with dementia and some other neurological disorders, Alzheimer Dis Assoc Disord 12 (1998), 26-32.
60. B. De Strooper, Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex, Neuron 38 (2003), 9-12.
61. M.A. Deibel, W.D. Ehmann and W.R. Markesbery, Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress, J Neurol Sci 143 (1996), 137-142.
62. J. Dong, C.S. Atwood, V.E. Anderson, S.L. Siedlak, M.A. Smith, G. Perry and P.R. Carey, Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence, Biochemistry 42 (2003), 2768-2773.
63. G.R. Eagle, R.R. Zombola and R.H. Himes, Tubulin-zinc interactions: binding and polymerization studies, Biochemistry 22 (1983), 221-228.
64. J.T. Egana, C. Zambrano, M.T. Nunez, C. Gonzalez-Billault and R.B. Maccioni, Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures, Biometals 16 (2003), 215-223.
65. C. Ekmekcioglu, The role of trace elements for the health of elderly individuals, Nahrung 45 (2001), 309-316.
66. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, M.P. Frosch, C.B. Eckman, R.E. Tanzi, D.J. Selkoe and S. Guenette, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc Natl Acad Sci USA 100 (2003), 4162-4167.
67. W.F. Forbes and G.B. Hill, Is exposure to aluminum a risk factor for the development of Alzheimer disease? - Yes, Arch Neurol 55 (1998), 740-741.
68. J.J.R. Frausto da Silva and R.J.P. Williams, The biological chemistry of the elements, Oxford University Press, Oxford, 2001.
69. P. Friedhoff, M. Von Bergen, E.M. Mandelkow, P. Davies and E. Mandelkow, A nucleated assembly mechanism of Alzheimer paired helical filaments, Proc Natl Acad Sci USA 95 (1998), 15712-15717.
70. P. Friedhoff, M. Von Bergen, E.M. Mandelkow and E. Mandelkow, Structure of tau protein and assembly into paired helical filaments, Biochim Biophys Acta 1502 (2000), 122-132.
71. A.L. Friedlich, J.Y. Lee, T. van Groen, R.A. Cherny, I. Volitakis, T.B. Cole, R.D. Palmiter, J.Y. Koh and A.I. Bush, Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease, J Neurosci 24 (2004), 3453-3459.
72. S.P. Gabbita, M.A. Lovell and W.R. Markesbery, Increased nuclear DNA oxidation in the brain in Alzheimer's disease, J Neurochem 71 (1998), 2034-2040.
73. A. Gafni, Structural modifications of proteins during aging, J Am Geriatr Soc 45 (1997), 871-880.
74. S. Gandy, The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease, J Clin Invest 115 (2005), 1121-1129.
75. W. Garzon-Rodriguez, A.K. Yatsimirsky and C.G. Glabe, Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence, Bioorg Med Chem Lett 9 (1999), 2243-2248.
76. F. Gaskin, In vitro microtubule assembly regulation by divalent cations and nucleotides, Biochemistry 20 (1981), 1318-1322.
77. F. Gaskin and Y. Kress, Zinc ion-induced assembly of tubulin, J Biol Chem 252 (1977), 6918-6924.
78. F. Gaskin and M.L. Shelanski, Microtubules and intermediate filaments, Essays Biochem 12 (1976), 115-146.
79. F.X. Gomis-Ruth, Structural aspects of the metzincin clan of metalloendopeptidases, Mol Biotechnol 24 (2003), 157-202.
80. P.E. Gonzales, A. Solomon, A.B. Miller, M.A. Leesnitzer, I. Sagi and M.E. Milla, Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain, J Biol Chem 279 (2004), 31638-31645.
81. B.L. Goode, M. Chau, P.E. Denis and S.C. Feinstein, Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease, J Biol Chem 275 (2000), 38182-38189.
82. R.W. Gracy, M.L. Chapman, J.K. Cini, M. Jahani, T.O. Tollefsbol and K.U. Yuksel, Molecular basis of the accumulation of abnormal proteins in progeria and aging fibroblasts, Basic Life Sci 35 (1985), 427-442.
83. I. Grundke-Iqbal, J. Fleming, Y.C. Tung, H. Lassmann, K. Iqbal and J.G. Joshi, Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia, Acta Neuropathol (Berl) 81 (1990), 105-110.
84. V.B. Gupta, S. Anitha, M.L. Hegde, L. Zecca, R.M. Garruto, R. Ravid, S.K. Shankar, R. Stein, P. Shanmugavelu and K.S. Jagannatha Rao, Aluminium in Alzheimer's disease: are we still at a crossroad? Cell Mol Life Sci 62 (2005), 143-158.
85. B. Halliwell and J.M. Gutteridge, Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem J 219 (1984), 1-14.
86. A. Hara and T. Taketomi, Cerebral lipid and protein abnormalities in Menkes' steely-hair disease, Jpn J Exp Med 56 (1986), 277-284.
87. F.M. Harris, W.J. Brecht, Q. Xu, R.W. Mahley and Y. Huang, Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc, J Biol Chem 279 (2004), 44795-44801.
88. M.R. Hasan, D. Morishima, K. Tomita, M. Katsuki and S. Kotani, Identification of a 250 kDa putative microtubule-associated protein as bovine ferritin. Evidence for a ferritin-microtubule interaction, Febs J 272 (2005), 822-831.
89. E. Head, W. Garzon-Rodriguez, J.K. Johnson, I.T. Lott, C.W. Cotman and C. Glabe, Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome, Neurobiol Dis 8 (2001), 792-806.
90. J.E. Hesketh, Zinc-stimulated microtubule assembly and evidence for zinc binding to tubulin, Int J Biochem 14 (1982), 983-990.
91. L. Hesse, D. Beher, C.L. Masters and G. Multhaup, The beta A4 amyloid precursor protein binding to copper, FEBS Lett 349 (1994), 109-116.
92. D.E. Hoke, J.-L. Tan, N.T. Ilaya, J.G. Culvenor, S.J. Smith, A.R. White, C.L. Masters and G.M. Evin, In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc, Febs J (2005), in press.
93. X. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi and A.I. Bush, The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38 (1999), 7609-7616.
94. X. Huang, C.S. Atwood, R.D. Moir, M.A. Hartshorn, R.E. Tanzi and A.I. Bush, Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides, J Biol Inorg Chem 9 (2004), 954-960.
95. X. Huang, C.S. Atwood, R.D. Moir, M.A. Hartshorn, J.P. Vonsattel, R.E. Tanzi and A.I. Bush, Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors, J Biol Chem 272 (1997), 26464-26470.
96. X. Huang, M.P. Cuajungco, C.S. Atwood, M.A. Hartshorn, J.D. Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E. Goldstein, R.C. Scarpa, A.J. Saunders, J. Lim, R.D. Moir, C. Glabe, E.F. Bowden, C.L. Masters, D.P. Fairlie, R.E. Tanzi and A.I. Bush, Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem 274 (1999), 37111-37116.
97. B.T. Hyman, J.C. Augustinack and M. Ingelsson, Transcriptional and conformational changes of the tau molecule in Alzheimer's disease, Biochim Biophys Acta 1739 (2005), 150-157.
98. N.C. Inestrosa, W. Cerpa and L. Varela-Nallar, Copper brain homeostasis: Role of amyloid precursor protein and prion protein, IUBMB Life 57 (2005), 645-650.
99. H. Ischiropoulos and J.S. Beckman, Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111 (2003), 163-169.
100. M. Iskra, J. Patelski and W. Majewski, Concentrations of calcium, magnesium, zinc and copper in relation to free fatty acids and cholesterol in serum of atherosclerotic men, J Trace Elem Electrolytes Health Dis 7 (1993), 185-188.
101. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N.P. Gerard, C. Gerard, E. Hama, H.J. Lee and T.C. Saido, Metabolic regulation of brain Abeta by neprilysin, Science 292 (2001), 1550-1552.
102. N. Iwata, S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, E. Hosoki, M. Kawashima-Morishima, H.J. Lee, E. Hama, Y. Sekine-Aizawa and T.C. Saido, Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nat Med 6 (2000), 143-150.
103. H. Kanemitsu, T. Tomiyama and H. Mori, Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form, Neurosci Lett 350 (2003), 113-116.
104. J.W. Karr, H. Akintoye, L.J. Kaupp and V.A. Szalai, N-Terminal deletions modify the Cu2+ binding site in amyloidbeta, Biochemistry 44 (2005), 5478-5487.
105. Y. Ke, Y.Z. Chang, X.L. Duan, J.R. Du, L. Zhu, K. Wang, X.D. Yang, K.P. Ho and Z.M. Qian, Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain, Neurobiol Aging 26 (2005), 739-748.
106. C.L. Keen, L.A. Hanna, L. Lanoue, J.Y. Uriu-Adams, R.B. Rucker and M.S. Clegg, Developmental consequences of trace mineral deficiencies in rodents: acute and long-term effects, J Nutr 133 (2003), 1477S-1480S.
107. N.H. Kim, M.S. Jeong, S.Y. Choi and J. Hoon Kang, Oxidative modification of neurofilament-L by the Cu,Zn-superoxide dismutase and hydrogen peroxide system, Biochimie 86 (2004), 553-559.
108. N.H. Kim and J.H. Kang, Oxidative modification of neurofilament-L by copper-catalyzed reaction, J Biochem Mol Biol 36 (2003), 488-492.
109. I. Klatzo, H. Wisniewski and E. Streicher, Experimental Production of Neurofibrillary Degeneration. I. Light Microscopic Observations, J Neuropathol Exp Neurol 24 (1965), 187-199.
110. S. Lammich, E. Kojro, R. Postina, S. Gilbert, R. Pfeiffer, M. Jasionowski, C. Haass and F. Fahrenholz, Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc Natl Acad Sci USA 96 (1999), 3922-3927.
111. B.P. Lanphear, R. Hornung, J. Khoury, K. Yolton, P. Baghurst, D.C. Bellinger, R.L. Canfield, K.N. Dietrich, R. Bornschein, T. Greene, S.J. Rothenberg, H.L. Needleman, L. Schnaas, G. Wasserman, J. Graziano and R. Roberts, Lowlevel environmental lead exposure and children's intellectual function: an international pooled analysis, Environ Health Perspect 113 (2005), 894-899.
112. J.Y. Lee, T.B. Cole, R.D. Palmiter, S.W. Suh and J.Y. Koh, Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc Natl Acad Sci USA 99 (2002), 7705-7710.
113. J.Y. Lee, J.E. Friedman, I. Angel, A.Kozak and J.Y.Koh, The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice, Neurobiol Aging 25 (2004), 1315-1321.
114. M.A. Leissring, W. Farris, A.Y. Chang, D.M.Walsh, X. Wu, X. Sun, M.P. Frosch and D.J. Selkoe, Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death, Neuron 40 (2003), 1087-1093.
115. S. Leutner, A. Eckert and W.E. Muller, ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain, J Neural Transm 108 (2001), 955-967.
116. S.M. LeVine, Iron deposits in multiple sclerosis and Alzheimer's disease brains, Brain Res 760 (1997), 298-303.
117. K. Liliom, G. Wagner, J. Kovacs, B. Comin, M. Cascante, F. Orosz and J. Ovadi, Combined enhancement of microtubule assembly and glucose metabolism in neuronal systems in vitro: decreased sensitivity to copper toxicity, Biochem Biophys Res Commun 264 (1999), 605-610.
118. S.E. Lind, J.R. McDonagh and C.J. Smith, Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate, Blood 82 (1993), 1522-1531.
119. R.D. Lindeman, M.L. Clark and J.P. Colmore, Influence of age and sex on plasma and red-cell zinc concentrations, J Gerontol 26 (1971), 358-363.
120. Y. Ling, K. Morgan and N. Kalsheker, Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease, Int J Biochem Cell Biol 35 (2003), 1505-1535.
121. S.T. Liu, G. Howlett and C.J. Barrow, Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease, Biochemistry 38 (1999), 9373-9378.
122. D.A. Loeffler, P.A. LeWitt, P.L. Juneau, A.A. Sima, H.U. Nguyen, A.J. DeMaggio, C.M. Brickman, G.J. Brewer, R.D. Dick, M.D. Troyer and L. Kanaley, Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders, Brain Res 738 (1996), 265-274.
123. C. Loske, A. Gerdemann, W. Schepl, M. Wycislo, R. Schinzel, D. Palm, P. Riederer and G. Munch, Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide, Eur J Biochem 267 (2000), 4171-4178.
124. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
125. M.A. Lovell, J.L. Smith, S. Xiong and W.R. Markesbery, Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and latestage Alzheimer's disease, Neurotox Res 7 (2005), 265-271.
126. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel and J. Rogers, Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am J Pathol 155 (1999), 853-862.
127. Y. Luo, B. Bolon, S. Kahn, B.D. Bennett, S. Babu-Khan, P. Denis, W. Fan, H. Kha, J. Zhang, Y. Gong, L. Martin, J.C. Louis, Q. Yan, W.G. Richards, M. Citron and R. Vassar, Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation, Nat Neurosci 4 (2001), 231-232.
128. S. Lutsenko and M.J. Petris, Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches, J Membr Biol 191 (2003), 1-12.
129. Q. Ma, Y. Li, J. Du, H. Liu, K. Kanazawa, T. Nemoto, H. Nakanishi and Y. Zhao, Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS, Peptides (2005).
130. Q.F. Ma, Y.M. Li, J.T. Du, K. Kanazawa, T. Nemoto, H. Nakanishi and Y.F. Zhao, Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR, Biopolymers 79 (2005), 74-85.
131. A. Madaric, E. Ginter and J. Kadrabova, Serum copper, zinc and copper/zinc ratio in males: influence of aging, Physiol Res 43 (1994), 107-111.
132. E. Martinez Lista, J. Sole, L. Arola and A. Mas, Changes in plasma copper and zinc during rat development, Biol Neonate 64 (1993), 47-52.
133. M.P. Mattson, Pathways towards and away from Alzheimer's disease, Nature 430 (2004), 631-639.
134. I. Maurer, S. Zierz and H.J. Moller, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, Neurobiol Aging 21 (2000), 455-462.
135. C.J. Maynard, R. Cappai, I. Volitakis, R.A. Cherny, A.R. White, K. Beyreuther, C.L. Masters, A.I. Bush and Q.X. Li, Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron, J Biol Chem 277 (2002), 44670-44676.
136. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush and C.L. Masters, Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann Neurol 46 (1999), 860-866.
137. D. McMaster, E. McCrum, C.C. Patterson, M.M. Kerr, D. O'Reilly, A.E. Evans and A.H. Love, Serum copper and zinc in random samples of the population of Northern Ireland, Am J Clin Nutr 56 (1992), 440-446.
138. Y. Mekmouche, Y. Coppel, K. Hochgrafe, L. Guilloreau, C. Talmard, H. Mazarguil and P. Faller, Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease, Chembiochem 6 (2005), 1663-1671.
139. A. Menditto, G. Morisi, A. Alimonti, S. Caroli, F. Petrucci, A. Spagnolo and A. Menotti, Association of serum copper and zinc with serum electrolytes and with selected risk factors for cardiovascular disease in men aged 55-75 years. NFR Study Group, J Trace Elem Electrolytes Health Dis 7 (1993), 251-253.
140. D.B. Milne and P.E. Johnson, Assessment of copper status: effect of age and gender on reference ranges in healthy adults, Clin Chem 39 (1993), 883-887.
141. T. Miura, K. Suzuki, N. Kohata and H. Takeuchi, Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes, Biochemistry 39 (2000), 7024-7031.
142. J.A. Molina, F.J. Jimenez-Jimenez, M.V. Aguilar, I. Meseguer, C.J. Mateos-Vega, M.J. Gonzalez-Munoz, F. de Bustos, J. Porta, M. Orti-Pareja, M. Zurdo, E. Barrios and M.C. Martinez-Para, Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease, J Neural Transm 105 (1998), 479-488.
143. A.L. Monget, P. Galan, P. Preziosi, H. Keller, C. Bourgeois, J. Arnaud, A. Favier and S. Hercberg, Micronutrient status in elderly people. Geriatrie/Min. Vit. Aux Network, Int J Vitam Nutr Res 66 (1996), 71-76.
144. P.I. Moreira, S.L. Siedlak, G. Aliev, X. Zhu, A.D. Cash, M.A. Smith and G. Perry, Oxidative stress mechanisms and potential therapeutics in Alzheimer disease, J Neural Transm 112 (2005), 921-932.
145. C.M. Morris, J.M. Kerwin and J.A. Edwardson, Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus, Neurodegeneration 3 (1994), 267-275.
146. J. Moskovitz, S. Bar-Noy, W.M. Williams, J. Requena, B.S. Berlett and E.R. Stadtman, Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals, Proc Natl Acad Sci USA 98 (2001), 12920-12925.
147. G. Multhaup, A.I. Bush, P. Pollwein and C.L. Masters, Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP), FEBS Lett 355 (1994), 151-154.
148. G. Multhaup, A. Schlicksupp, L. Hesse, D. Beher, T. Ruppert, C.L. Masters and K. Beyreuther, The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I), Science 271 (1996), 1406-1409.
149. D.G. Munoz, Is exposure to aluminum a risk factor for the development of Alzheimer disease? - No, Arch Neurol 55 (1998), 737-739.
150. H.N. Munro, P.M. Suter and R.M. Russell, Nutritional requirements of the elderly, Annu Rev Nutr 7 (1987), 23-49.
151. T. Nystrom, Role of oxidative carbonylation in protein quality control and senescence, Embo J 24 (2005), 1311-1317.
152. R.A. Omar, Y.J. Chyan, A.C. Andorn, B. Poeggeler, N.K. Robakis and M.A. Pappolla, Increased Expression but Reduced Activity of Antioxidant Enzymes in Alzheimer's Disease, J Alzheimers Dis 1 (1999), 139-145.
153. C. Opazo, X. Huang, R.A. Cherny, R.D. Moir, A.E. Roher, A.R. White, R. Cappai, C.L. Masters, R.E. Tanzi, N.C. Inestrosa and A.I. Bush, Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2), J Biol Chem 277 (2002), 40302-40308.
154. C. Opazo, S. Luza, V.L. Villemagne, I. Volitakis, C. Rowe, K.J. Barnham, D. Strozyk, C.L. Masters, R.A. Cherny and A.I. Bush, Radioiodinated clioquinol as a biomarker for ßamyloid: Zn2+ complexes in Alzheimer's disease, Aging Cell in press.
155. C. Opazo, F.H. Ruiz and N.C. Inestrosa, Amyloid-beta-peptide reduces copper(II) to copper(I) independent of its aggregation state, Biol Res 33 (2000), 125-131.
156. E. Ortiz, J.M. Pasquini, K. Thompson, B. Felt, G. Butkus, J. Beard and J.R. Connor, Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models, J Neurosci Res 77 (2004), 681-689.
157. P.I. Oteiza, S. Cuellar, B. Lonnerdal, L.S. Hurley and C.L. Keen, Influence of maternal dietary zinc intake on in vitro tubulin polymerization in fetal rat brain, Teratology 41 (1990), 97-104.
158. P.I. Oteiza, L.S. Hurley, B. Lonnerdal and C.L. Keen, Effects of marginal zinc deficiency on microtubule polymerization in the developing rat brain, Biol Trace Elem Res 24 (1990), 13-23.
159. M.A. Pappolla, R.A. Omar, K.S. Kim and N.K. Robakis, Immunohistochemical evidence of oxidative corrected stress in Alzheimer's disease, Am J Pathol 140 (1992), 621-628.
160. I.H. Park, M.W. Jung, H. Mori and I. Mook-Jung, Zinc enhances synthesis of presenilin 1 in mouse primary cortical culture, Biochem Biophys Res Commun 285 (2001), 680-688.
161. N.V. Patel, M.N. Gordon, K.E. Connor, R.A. Good, R.W. Engelman, J. Mason, D.G. Morgan, T.E. Morgan and C.E. Finch, Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models, Neurobiol Aging 26 (2005), 995-1000.
162. S.S. Percival, Copper and immunity, Am J Clin Nutr 67 (1998), 1064S-1068S.
163. M. Perez, J.M. Valpuesta, E.M. de Garcini, C. Quintana, M. Arrasate, J.L. Lopez Carrascosa, A. Rabano, J. Garcia de Yebenes and J. Avila, Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy, Am J Pathol 152 (1998), 1531-1539.
164. G. Perry, A.D. Cash and M.A. Smith, Alzheimer Disease and Oxidative Stress, J Biomed Biotechnol 2 (2002), 120-123.
165. A.L. Phinney, B. Drisaldi, S.D. Schmidt, S. Lugowski, V. Coronado, Y. Liang, P. Horne, J. Yang, J. Sekoulidis, J. Coomaraswamy, M.A. Chishti, D.W. Cox, P.M. Mathews, R.A. Nixon, G.A. Carlson, P. St George-Hyslop and D.Westaway, In vivo reduction of amyloid-beta by a mutant copper transporter, Proc Natl Acad Sci USA 100 (2003), 14193-14198.
166. K.B. Pierson and M.A. Evenson, 200 Kd neurofilament protein binds Al, Cu and Zn, Biochem Biophys Res Commun 152 (1988), 598-604.
167. L.-O. Plantin, U. Lysing-Tunnell and K. Kristensson, Trace elements in the human central nervous system studied with neutron activation analysis, Biol Trace Elem Res (1987), 69-75.
168. A.S. Prasad, J.T. Fitzgerald, J.W. Hess, J. Kaplan, F. Pelen and M. Dardenne, Zinc deficiency in elderly patients, Nutrition 9 (1993), 218-224.
169. J.R. Prohaska and A.A. Gybina, Intracellular copper transport in mammals, J Nutr 134 (2004), 1003-1006.
170. L. Puglielli, A.L. Friedlich, K.D. Setchell, S. Nagano, C. Opazo, R.A. Cherny, K.J. Barnham, J.D. Wade, S. Melov, D.M. Kovacs and A.I. Bush, Alzheimer disease beta-amyloid activity mimics cholesterol oxidase, J Clin Invest 115 (2005), 2556-2563.
171. M.E. Quinta-Ferreira and C.M. Matias, Tetanically released zinc inhibits hippocampal mossy fiber calcium, zinc and synaptic responses, Brain Res 1047 (2005), 1-9.
172. T.D. Rae, P.J. Schmidt, R.A. Pufahl, V.C. Culotta and T.V. O'Halloran, Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase, Science 284 (1999), 805-808.
173. M.T. Rajan, K.S. Jagannatha Rao, B.M. Mamatha, R.V. Rao, P. Shanmugavelu, R.B. Menon and M.V. Pavithran, Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry, J Neurol Sci 146 (1997), 153-166.
174. B. Raman, T. Ban, K. Yamaguchi, M. Sakai, T. Kawai, H. Naiki and Y. Goto, Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide, J Biol Chem 280 (2005), 16157-16162.
175. K.S.J. Rao, R.V. Rao, P. Shanmugavelu and R.B. Menon, Trace elements in Alzheimer's disease brain: A new hypothesis, In Alzheimer's Reports (1999), 241-246.
176. G. Ravaglia, P. Forti, F. Maioli, B. Nesi, L. Pratelli, L. Savarino, D. Cucinotta and G. Cavalli, Blood micronutrient and thyroid hormone concentrations in the oldest-old, J Clin Endocrinol Metab 85 (2000), 2260-2265.
177. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R.E. Tanzi and C.L. Masters, Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial, Arch Neurol 60 (2003), 1685-1691.
178. J.T. Rogers, J.D. Randall, C.M. Cahill, P.S. Eder, X. Huang, H. Gunshin, L. Leiter, J. McPhee, S.S. Sarang, T. Utsuki, N.H. Greig, D.K. Lahiri, R.E. Tanzi, A.I. Bush, T. Giordano and S.R. Gullans, An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript, J Biol Chem 277 (2002), 45518-45528.
179. R.F. Rosenberger, Senescence and the accumulation of abnormal proteins, Mutat Res 256 (1991), 255-262.
180. L. Rossi, M.F. Lombardo, M.R. Ciriolo and G. Rotilio, Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance, Neurochem Res 29 (2004), 493-504.
181. C.A. Rottkamp, A.K. Raina, X. Zhu, E. Gaier, A.I. Bush, C.S. Atwood, M. Chevion, G. Perry and M.A. Smith, Redoxactive iron mediates amyloid-beta toxicity, Free Radic Biol Med 30 (2001), 447-450.
182. F.H. Ruiz, M. Gonzalez, M. Bodini, C. Opazo and N.C. Inestrosa, Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein, J Neurochem 73 (1999), 1288-1292.
183. Y. Sagara, R. Dargusch, F.G. Klier, D. Schubert and C. Behl, Increased antioxidant enzyme activity in amyloid beta protein-resistant cells, J Neurosci 16 (1996), 497-505.
184. A. Sanz, P. Caro, J. Ibanez, J. Gomez, R. Gredilla and G. Barja, Dietary restriction at old age lowers mitochondrial oxygen radical production and leak at complex I and oxidative DNA damage in rat brain, J Bioenerg Biomembr 37 (2005), 83-90.
185. L.M. Sayre, G. Perry, P.L. Harris, Y. Liu, K.A. Schubert and M.A. Smith, In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals, J Neurochem 74 (2000), 270-279.
186. S. Scheuermann, B. Hambsch, L. Hesse, J. Stumm, C. Schmidt, D. Beher, T.A. Bayer, K. Beyreuther and G. Multhaup, Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease, J Biol Chem 276 (2001), 33923-33929.
187. M.L. Schlief, A.M. Craig and J.D. Gitlin, NMDA receptor activation mediates copper homeostasis in hippocampal neurons, J Neurosci 25 (2005), 239-246.
188. S.E. Schriner, N.J. Linford, G.M. Martin, P. Treuting, C.E. Ogburn, M. Emond, P.E. Coskun, W. Ladiges, N. Wolf, H. Van Remmen, D.C.Wallace and P.S. Rabinovitch, Extension of murine life span by overexpression of catalase targeted to mitochondria, Science 308 (2005), 1909-1911.
189. D. Schubert and M. Chevion, The role of iron in beta amyloid toxicity, Biochem Biophys Res Commun 216 (1995), 702-707.
190. K. Schuessel, S. Schafer, T.A. Bayer, C. Czech, L. Pradier, F. Muller-Spahn, W.E. Muller and A. Eckert, Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice, Neurobiol Dis 18 (2005), 89-99.
191. M.L. Selley, D.R. Close and S.E. Stern, The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease, Neurobiol Aging 23 (2002), 383-388.
192. L. Serrano, J.E. Dominguez and J. Avila, Identification of zinc-binding sites of proteins: zinc binds to the amino-terminal region of tubulin, Anal Biochem 172 (1988), 210-218.
193. H. Shinall, E.S. Song and L.B. Hersh, Susceptibility of amyloid β peptide degrading enzymes to oxidative damage: A potential Alzheimer's Disease spiral, Biochemistry (2005), in press.
194. B.D. Shivers, C. Hilbich, G. Multhaup, M. Salbaum, K. Beyreuther and P.H. Seeburg, Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact, Embo J 7 (1988), 1365-1370.
195. A. Simons, T. Ruppert, C. Schmidt, A. Schlicksupp, R. Pipkorn, J. Reed, C.L. Masters, A.R. White, R. Cappai, K. Beyreuther, T.A. Bayer and G. Multhaup, Evidence for a copper-binding superfamily of the amyloid precursor protein, Biochemistry 41 (2002), 9310-9320.
196. S. Sinha, J.P. Anderson, R. Barbour, G.S. Basi, R. Caccavello, D. Davis, M. Doan, H.F. Dovey, N. Frigon, J. Hong, K. Jacobson-Croak, N. Jewett, P. Keim, J. Knops, I. Lieberburg, M. Power, H. Tan, G. Tatsuno, J. Tung, D. Schenk, P. Seubert, S.M. Suomensaari, S.Wang, D.Walker, J. Zhao, L. McConlogue and V. John, Purification and cloning of amyloid precursor protein beta-secretase from human brain, Nature 402 (1999), 537-540.
197. M.A. Smith, K. Wehr, P.L. Harris, S.L. Siedlak, J.R. Connor and G. Perry, Abnormal localization of iron regulatory protein in Alzheimer's disease, Brain Res 788 (1998), 232-236.
198. D.L. Sparks and B.G. Schreurs, Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease, Proc Natl Acad Sci USA 100 (2003), 11065-11069.
199. T.C. Squier, Oxidative stress and protein aggregation during biological aging, Exp Gerontol 36 (2001), 1539-1550.
200. R. Squitti, E. Cassetta, G. Dal Forno, D. Lupoi, G. Lippolis, F. Pauri, F. Vernieri, A. Cappa and P.M. Rossini, Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment, Arch Neurol 61 (2004), 738-743.
201. R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta and P.M. Rossini, Elevation of serum copper levels in Alzheimer's disease, Neurology 59 (2002), 1153-1161.
202. S.W. Suh, K.B. Jensen, M.S. Jensen, D.S. Silva, P.J. Kesslak, G. Danscher and C.J. Frederickson, Histochemicallyreactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains, Brain Res 852 (2000), 274-278.
203. Y.H. Suh and F. Checler, Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease, Pharmacol Rev 54 (2002), 469-525.
204. P.G. Sullivan and M.R. Brown, Mitochondrial aging and dysfunction in Alzheimer's disease, Prog Neuropsychopharmacol Biol Psychiatry 29 (2005), 407-410.
205. C.D. Syme, R.C. Nadal, S.E. Rigby and J.H. Viles, Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques, J Biol Chem 279 (2004), 18169-18177.
206. A. Takeda, Zinc homeostasis and functions of zinc in the brain, Biometals 14 (2001), 343-351.
207. T. Tarohda, M. Yamamoto and R. Amamo, Regional distribution of manganese, iron, copper, and zinc in the rat brain during development, Anal Bioanal Chem 380 (2004), 240-246.
208. R.D. Terry, The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis, J Neuropathol Exp Neurol 55 (1996), 1023-1025.
209. C. Treiber, A. Simons, M. Strauss, M. Hafner, R. Cappai, T.A. Bayer and G. Multhaup, Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease, J Biol Chem 279 (2004), 51958-51964.
210. Y. Uchida, K. Takio, K. Titani, Y. Ihara and M. Tomonaga, The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein, Neuron 7 (1991), 337-347.
211. D. Valensin, F.M. Mancini, M. Luczkowski, A. Janicka, K. Wisniewska, E. Gaggelli, G. Valensin, L. Lankiewicz and H. Kozlowski, Identification of a novel high affinity copper binding site in the APP(145-155) fragment of amyloid precursor protein, Dalton Trans (2004), 16-22.
212. M. Valko, H. Morris and M.T. Cronin, Metals, toxicity and oxidative stress, Curr Med Chem 12 (2005), 1161-1208.
213. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers and M. Citron, Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science 286 (1999), 735-741.
214. A. Venti, T. Giordano, P. Eder, A.I. Bush, D.K. Lahiri, N.H. Greig and J.T. Rogers, The Integrated Role of Desferrioxamine and Phenserine Targeted to an Iron-Responsive Element in the APP-mRNA 5′-Untranslated Region, Ann N Y Acad Sci 1035 (2004), 34-48.
215. J.C. Vickers, T.C. Dickson, P.A. Adlard, H.L. Saunders, C.E. King and G. McCormack, The cause of neuronal degeneration in Alzheimer's disease, Prog Neurobiol 60 (2000), 139-165.
216. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S.Wolfe, M.J. Rowan and D.J. Selkoe, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416 (2002), 535-539.
217. D.M. Walsh, I. Klyubin, J.V. Fadeeva, M.J. Rowan and D.J. Selkoe, Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition, Biochem Soc Trans 30 (2002), 552-557.
218. D.S.Wang, N. Iwata, E. Hama, T.C. Saido and D.W. Dickson, Oxidized neprilysin in aging and Alzheimer's disease brains, Biochem Biophys Res Commun 310 (2003), 236-241.
219. J. Wang, D.W. Dickson, J.Q. Trojanowski and V.M. Lee, The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging, Exp Neurol 158 (1999), 328-337.
220. J. Wang, L. Ho, W. Qin, A.B. Rocher, I. Seror, N. Humala, K. Maniar, G. Dolios, R.Wang, P.R. Hof and G.M. Pasinetti, Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease, Faseb J 19 (2005), 659-661.
221. M. Wegner, Transcriptional control in myelinating glia: the basic recipe, Glia 29 (2000), 118-123.
222. R.C.Weisenberg, Microtubule formation in vitro in solutions containing low calcium concentrations, Science 177 (1972), 1104-1105.
223. M.G. Weisskopf, R.O. Wright, J. Schwartz, A. Spiro, 3rd, D. Sparrow, A. Aro and H. Hu, Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study, Am J Epidemiol 160 (2004), 1184-1193.
224. M.Wender, J. Szczech, S. Hoffmann and W. Hilczer, Electron paramagnetic resonance analysis of heavy metals in the aging human brain, Neuropatol Pol 30 (1992), 65-72.
225. A.R. White, R. Reyes, J.F. Mercer, J. Camakaris, H. Zheng, A.I. Bush, G. Multhaup, K. Beyreuther, C.L. Masters and R. Cappai, Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice, Brain Res 842 (1999), 439-444.
226. H. Wille, G. Drewes, J. Biernat, E.M. Mandelkow and E. Mandelkow, Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro, J Cell Biol 118 (1992), 573-584.
227. M. Yamaguchi, M. Kura and S. Okada, Role of zinc as an activator of mitochondrial function in rat liver, Biochem Pharmacol 31 (1982), 1289-1293.
228. A. Yamamoto, R.W. Shin, K. Hasegawa, H. Naiki, H. Sato, F. Yoshimasu and T. Kitamoto, Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease, J Neurochem 82 (2002), 1137-1147.
229. R. Yan, M.J. Bienkowski, M.E. Shuck, H. Miao, M.C. Tory, A.M. Pauley, J.R. Brashier, N.C. Stratman, W.R. Mathews, A.E. Buhl, D.B. Carter, A.G. Tomasselli, L.A. Parodi, R.L. Heinrikson and M.E. Gurney, Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity, Nature 402 (1999), 533-537.
230. D.S.Yang, J. McLaurin, K. Qin, D. Westaway and P.E. Fraser, Examining the zinc binding site of the amyloid-beta peptide, Eur J Biochem 267 (2000), 6692-6698.
231. V.W. Yong, C.A. Krekoski, P.A. Forsyth, R. Bell and D.R. Edwards, Matrix metalloproteinases and diseases of the CNS, Trends Neurosci 21 (1998), 75-80.
232. Y. Yoshiike, K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sato, X. Sun, N. Tanaka and A. Takashima, New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity, J Biol Chem 276 (2001), 32293-32299.
233. M.B. Youdim and S. Yehuda, The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system, Cell Mol Biol (Noisy-legrand) 46 (2000), 491-500.
234. W.H. Yu, W.J. Lukiw, C. Bergeron, H.B. Niznik and P.E. Fraser, Metallothionein III is reduced in Alzheimer's disease, Brain Res 894 (2001), 37-45.
235. F.P. Zemlan, O.J. Thienhaus and H.B. Bosmann, Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation, Brain Res 476 (1989), 160-162.